An assessment of legislative responses to cancer in Brazil’s House of Representatives

IF 2 Q3 HEALTH POLICY & SERVICES Journal of Cancer Policy Pub Date : 2023-09-01 DOI:10.1016/j.jcpo.2023.100429
Lucas Hernandes Corrêa , Marina Martins Siqueira , Fernando Cotait Maluf
{"title":"An assessment of legislative responses to cancer in Brazil’s House of Representatives","authors":"Lucas Hernandes Corrêa ,&nbsp;Marina Martins Siqueira ,&nbsp;Fernando Cotait Maluf","doi":"10.1016/j.jcpo.2023.100429","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cancer is a public health issue in Brazil. To mitigate exposure to risk factors, change habits and ensure access to cancer care, an increasing number of bills are presented every year. This article analyzes the changes proposed in these bills, portraying how the representatives perceive and respond to the challenges imposed by cancer on the healthcare system and society.</p></div><div><h3>Methods</h3><p>Through a systematic search on the Brazilian House of Representatives website, this exploratory study examines cancer-related bills presented up to 2022.</p></div><div><h3>Results</h3><p>Of 1311 bills identified, 310 met the inclusion criteria and were categorized based on their content. The increasing annual number of cancer bills reflects the interest of representatives on the topic. The cancer types addressed correspond to the most prevalent ones, except for the colorectal. The most common strategy is primary prevention (n: 129), proposing the reduction of risk factors exposure or the promotion of protective ones, followed by tertiary (n: 106) and secondary (n: 36) strategies, targeting, respectively, cancer treatment/management and its early diagnosis/detection. On the nature of proposed changes, most seek to implement increased healthcare access (n: 125), production/sale (dis)incentives for goods containing carcinogens (n: 60), and fiscal/financial (dis)incentives (n: 53).</p></div><div><h3>Conclusion</h3><p>The identified gaps - such as the limited use of data and evidence to support what is proposed, overlapping but fragmented efforts with previous bills, scarce efforts directly addressing the determinants of health, and the low rate of conversion to law - entails opportunities to advance the Legislative propositions.</p></div><div><h3>Policy summary</h3><p>To effectively respond to cancer-related challenges, is essential that the Legislative branch takes into account what is already being proposed or being left out, inputs from society, real-world data, and the results produced by the multisectoral policies in place.</p></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538323000462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Cancer is a public health issue in Brazil. To mitigate exposure to risk factors, change habits and ensure access to cancer care, an increasing number of bills are presented every year. This article analyzes the changes proposed in these bills, portraying how the representatives perceive and respond to the challenges imposed by cancer on the healthcare system and society.

Methods

Through a systematic search on the Brazilian House of Representatives website, this exploratory study examines cancer-related bills presented up to 2022.

Results

Of 1311 bills identified, 310 met the inclusion criteria and were categorized based on their content. The increasing annual number of cancer bills reflects the interest of representatives on the topic. The cancer types addressed correspond to the most prevalent ones, except for the colorectal. The most common strategy is primary prevention (n: 129), proposing the reduction of risk factors exposure or the promotion of protective ones, followed by tertiary (n: 106) and secondary (n: 36) strategies, targeting, respectively, cancer treatment/management and its early diagnosis/detection. On the nature of proposed changes, most seek to implement increased healthcare access (n: 125), production/sale (dis)incentives for goods containing carcinogens (n: 60), and fiscal/financial (dis)incentives (n: 53).

Conclusion

The identified gaps - such as the limited use of data and evidence to support what is proposed, overlapping but fragmented efforts with previous bills, scarce efforts directly addressing the determinants of health, and the low rate of conversion to law - entails opportunities to advance the Legislative propositions.

Policy summary

To effectively respond to cancer-related challenges, is essential that the Legislative branch takes into account what is already being proposed or being left out, inputs from society, real-world data, and the results produced by the multisectoral policies in place.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴西众议院对癌症立法对策的评估
背景癌症是巴西的一个公共卫生问题。为了减少风险因素的暴露,改变习惯,确保获得癌症治疗,每年都会提交越来越多的账单。本文分析了这些法案中提出的修改,描述了代表们如何看待和应对癌症给医疗系统和社会带来的挑战。方法通过在巴西众议院网站上的系统搜索,这项探索性研究检查了截至2022年提交的癌症相关法案。结果在1311份法案中,310份符合纳入标准,并根据其内容进行了分类。每年癌症法案数量的增加反映了代表们对这一议题的兴趣。所述癌症类型对应于最常见的癌症类型,但结肠直肠癌除外。最常见的策略是一级预防(n:129),建议减少风险因素暴露或促进保护性风险因素暴露,其次是三级(n:106)和二级策略(n:36),分别针对癌症的治疗/管理及其早期诊断/检测。关于拟议改革的性质,大多数人寻求实施更多的医疗保健机会(n:125)、对含有致癌物的商品的生产/销售(dis)激励措施(n:60)和财政/金融(dis,直接解决健康决定因素的努力很少,而且法律转化率低,这就带来了推进立法主张的机会。政策摘要为了有效应对与癌症相关的挑战,立法部门必须考虑到已经提出或遗漏的建议、社会的投入、现实世界的数据以及现有多部门政策产生的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
期刊最新文献
Palliative Care in Turkey: Insights from experts through key informant interviews Is health-related quality of life sufficiently addressed in trials for breast cancer treatments? An assessment based on reimbursement opinions from the French health technology assessment body, 2009–2023 Shaping the future research agenda of Cancer Nursing in Italy: Insights and strategic directions Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients Artificial Intelligence and cancer: Profile of registered clinical trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1